Clinical performance study completed
Cellda receives a travel grant
Cellda completes a new share issue of approximately SEK 3,7 million
Cellda welcomes two new board members
Cellda at GoWest Nordic Capital Forum
Supporter to “10th Digital Pathology & AI Congress: Europe” Conference in London
New team member to Cellda AB
Collaboration agreement for market entry
New CEO of Cellda AB
Name change of company to Cellda AB
Discover how Cellda AB is revolutionizing prostate cancer diagnostics. Join the future today.
Search
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.